MiraOne: Your DNA, Blood, and Meds in One Report

A groundbreaking blood test named MiraOne was recently launched in Mumbai, promising to transform personalized healthcare. This comprehensive test operates on the principle of "One test, One you," generating three distinct reports from a single blood draw to provide a holistic view of an individual's health.

MiraOne integrates three critical layers of information: blood chemistry, inherited DNA, and how a person's genes affect their response to medications. Unlike conventional tests that might identify a problem like elevated homocysteine, MiraOne delves deeper to explain the underlying genetic reasons and identify the most effective treatments. It achieves this by sequencing 120 million DNA positions, significantly more than the typical 80,000, to identify subtle genetic mutations.

Co-founded by Nickhil Jakatdar and Abhinav Kejriwal, MiraOne aims to deliver on the long-promised potential of personalized medicine. The test combines blood analysis, whole exome sequencing, and pharmacogenomics into a consumer-friendly report designed for discussion with a healthcare provider. This approach moves away from a one-size-fits-all model towards precision medicine, offering clarity and a definitive path forward instead of guesswork.